000			05879cam a2200445Ii 4500
988			_aSpringer_Medicine_2017
999			_c95709 _d95709 _x1
001			95709
003			ES-MaUEC
005			20230102112718.0
006			m o d
007			cr cnu|||unuuu
008			170403s2017 si a o 000 0 eng d
020			_a9789811030529
020			_a9789811030536 _q(electronic bk.)
020			_a9811030529
020			_a9811030537 _q(electronic bk.)
020			_z9789811030529 _q(print)
040			_aN$T _cN$T _dGW5XE _dEBLCP _dN$T _dYDX _dDKU _dIOG _dCOO _dAZU _dUPM _dESU _dVT2 _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dU3W _dMERUC _dES-MaUEC _bspa
050		4	_aRC694.3 _b2017 EB
245	0	0	_aPractical approach to peripheral arterial chronic total occlusions _cSubhash Banerjee, editor.
264		1	_aSingapore _bSpringer _c2017.
300			_a1 recurso en línea (ix, 122 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aSpringerLink
505	0		_aPreface; Acknowledgment and Dedication; Contents; Chapter 1: Medical Management of Lower Extremity Peripheral Artery Disease; 1.1 Introduction; 1.2 Risk Factor Modification; 1.2.1 Tobacco Use; 1.2.2 Hyperlipidemia, Hypertension, and Diabetes; 1.3 Therapeutics: Control of Risk Factors and CV Mortality and Morbidity; 1.3.1 Smoking Cessation Therapy; 1.3.2 Lipid Lower Therapy with Statins; 1.3.3 Hypertension Control with Angiotensin-Converting Enzyme Inhibition; 1.3.4 Antiplatelet Therapy; 1.4 Therapeutics: Improvement of Functional Capacity; 1.4.1 Supervised Exercise Therapy (SET).
505	8		_a1.4.2 Cilostazol1.5 Therapeutics: Investigational, Failed, and Other Therapies; 1.6 Conclusion; References; Chapter 2: Endovascular Treatment of Iliac Artery Chronic Total Occlusions; 2.1 Introduction; 2.2 Outcomes After Endovascular Treatment of Iliac CTOs; 2.3 Treatment Strategies and Illustrative Cases; 2.3.1 Overall Approach and Treatment Strategy; 2.3.2 Ostial Common Iliac or Aortic Bifurcation; 2.3.3 Non-ostial Common Iliac Artery and Proximal External Iliac Artery CTOs; 2.3.4 Distal External Iliac Artery CTOs; 2.4 Conclusions; References.
505	8		_a5.1 Introduction5.2 BTK CTOs: Indications and Treatment Options; 5.3 BTK CTOs: Prevalence, Angiosome Concept, and Pathology; 5.4 BTK CTOs: Endovascular Approach; 5.4.1 Access; 5.4.1.1 Access: Contralateral; 5.4.1.2 Access: Antegrade; 5.4.1.3 Access: Retrograde Pedal Access; 5.4.1.4 Access (and Treatment): Tibio-pedal Arterial Minimally Invasive Retrograde Revascularization (TAMI); 5.4.1.5 Access: Metatarsal and Direct Pedal Loop; 5.4.1.6 Access: Radial; 5.5 Crossing Approach; 5.5.1 Reentry; 5.5.2 Opposite Direction Wire Strategies; 5.5.3 Wire Capture.
505	8		_a5.5.4 Extravascular Ultrasound-Guided Crossing (EVUS)5.6 Treatment Strategies; 5.6.1 Balloon Angioplasty; 5.6.2 Bare Metal Stents; 5.6.3 Drug-Eluting Technologies; 5.6.3.1 Atherectomy; 5.7 Complications of BTK CTO Revascularization; 5.7.1 Distal Embolization; 5.7.2 Perforation; 5.8 Conclusions; References; Chapter 6: Comparative Assessment of Crossing and Reentry Devices in Treating Chronic Total Occlusions for Femoropopliteal and Below-Ưthe-ƯKnee Interventions; 6.1 Definitions; 6.2 Primary Crossing Devices Versus Primary Wire-ƯCatheter as Initial Crossing Strategy.
505	8		_aChapter 3: Femoropopliteal Artery Chronic Total Occlusion Intervention3.1 Retrograde FP CTO Intervention; 3.2 Transcutaneous Ultrasound-Guided Endovascular Crossing of FP CTO; 3.2.1 Peripheral Arterial Segments; 3.2.2 Transcollateral Approach to Femoropopliteal CTO; 3.2.3 "SAFARI" Technique; 3.2.4 Hybrid Approach to Femoropopliteal CTO Intervention; References; Chapter 4: Treatment of Femoropopliteal CTO; 4.1 Follow-up of Patients Following Successful Femoropopliteal CTO; 4.1.1 Intervention; References; Chapter 5: Endovascular Treatment of Below-the-Knee Chronic Total Occlusions.
520	3		_aA practical, highly illustrative and easy to read reference for interventional cardiologists, vascular surgeons, cardiac/endovascular catheterization laboratory personnel, interventional radiologists, technical staff, industry professionals, investigators, and researchers on peripheral arterial CTO interventions. Peripheral CTO lesions are present in nearly 50% of all peripheral arterial disease (PAD) endovascular interventions. There is tremendous growth in the performance and learning of peripheral arterial CTO procedures. There are several ongoing physician courses and many others that are being prepared; however, there is a significant lack of standardized selection, strategies, techniques and equipment necessary to achieve a high degree of reproducible success with low complication rates during the performance of these complex and technically challenging endovascular procedures. The book is not an academic ℓ́ℓtour de forceℓ́ℓ description of the topic but rather a practical one with many illustrations and step-by-step explanations of the various procedure steps, what can go wrong, and troubleshooting. Heavy use of illustrations throughout limit the text to what is necessary to convey the message, and the book is supported by online case catalogues and board review questions. The book also includes never-before-published information on new technology.
588	0		_aOnline resource; title from PDF title page (SpringerLink, viewed April 7, 2017).
650		7	_2embne _9140382 _aTrombosis
700	1		_aBanerjee, Subhash, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-3053-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI